Hepion Pharmaceuticals Inc (NASDAQ: HEPA) is -63.62% lower on its value in year-to-date trading and has touched a low of $0.12 and a high of $3.49 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HEPA stock was last observed hovering at around $0.17 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.17, the stock is -32.85% and -61.42% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 16.93 million and changing 1.30% at the moment leaves the stock -77.88% off its SMA200. HEPA registered -89.04% loss for a year compared to 6-month loss of -71.50%. The firm has a 50-day simple moving average (SMA 50) of $0.4535 and a 200-day simple moving average (SMA200) of $0.77979.
The stock witnessed a -69.48% gain in the last 1 month and extending the period to 3 months gives it a -73.32%, and is 5.43% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.61% over the week and 21.84% over the month.
Hepion Pharmaceuticals Inc (HEPA) has around 22 employees, a market worth around $1.81M and $0.00M in sales. Distance from 52-week low is 41.32% and -95.10% from its 52-week high.
.
Hepion Pharmaceuticals Inc (HEPA) Top Institutional Holders
27.0 institutions hold shares in Hepion Pharmaceuticals Inc (HEPA), with institutional investors hold 7.85% of the company’s shares. The shares outstanding are 10.62M, and float is at 10.61M with Short Float at 1.99%. Institutions hold 7.85% of the Float.
Hepion Pharmaceuticals Inc (HEPA) Insider Activity
#####
